These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21471648)

  • 1. Does adaptive cognitive testing combine efficiency with precision? Prospective findings.
    Wouters H; van Campen J; Appels B; Lindeboom R; Buiter M; de Haan RJ; Zwinderman AH; van Gool WA; Schmand B
    J Alzheimers Dis; 2011; 25(4):595-603. PubMed ID: 21471648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive cognitive testing in cerebrovascular disease and vascular dementia.
    Wouters H; de Koning I; Zwinderman AH; van Gool WA; Schmand B; Buiter M; Lindeboom R
    Dement Geriatr Cogn Disord; 2009; 28(5):486-92. PubMed ID: 19940481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the accuracy and precision of cognitive testing in mild dementia.
    Wouters H; Appels B; van der Flier WM; van Campen J; Klein M; Zwinderman AH; Schmand B; van Gool WA; Scheltens P; Lindeboom R
    J Int Neuropsychol Soc; 2012 Mar; 18(2):314-22. PubMed ID: 22206624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive cognitive testing in dementia.
    Wouters H; Zwinderman AH; van Gool WA; Schmand B; Lindeboom R
    Int J Methods Psychiatr Res; 2009 Jun; 18(2):118-27. PubMed ID: 19507163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized evaluation of cholinesterase inhibitors effects in dementia with adaptive cognitive testing.
    Wouters H; Van Campen JP; Appels BA; Beijnen JH; Zwinderman AH; Van Gool WA; Schmand B
    Int J Methods Psychiatr Res; 2016 Sep; 25(3):190-8. PubMed ID: 26299847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study.
    Radanovic M; Facco G; Forlenza OV
    Int J Geriatr Psychiatry; 2018 May; 33(5):769-778. PubMed ID: 29411413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).
    Zaidi S; Kat MG; de Jonghe JF
    Int Psychogeriatr; 2014 Jul; 26(7):1139-45. PubMed ID: 24622334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
    Heinik J; Kavé G
    Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CAMCOG: a useful screening instrument for dementia in stroke patients.
    de Koning I; van Kooten F; Dippel DW; van Harskamp F; Grobbee DE; Kluft C; Koudstaal PJ
    Stroke; 1998 Oct; 29(10):2080-6. PubMed ID: 9756586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clock Drawing Test--Modified and Integrated Approach (CDT-MIA) as an instrument for detecting mild cognitive impairment in a specialized outpatient setting.
    Heinik J; Shaikewitz D
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):171-80. PubMed ID: 19276409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
    Athey RJ; Walker RW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How valid are subjective ratings of prospective memory in mild cognitive impairment and early dementia?
    Thompson CL; Henry JD; Rendell PG; Withall A; Brodaty H
    Gerontology; 2015; 61(3):251-7. PubMed ID: 25792282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early Mental Test--developing a screening test for mild cognitive impairment].
    Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E
    Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia.
    de Koning I; van Kooten F; Koudstaal PJ; Dippel DW
    J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):263-5. PubMed ID: 15654047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is it pseudo-dementia? The validation of the Adas-Cog questionnaire in Hungary].
    Drótos G; Pákáski M; Papp E; Kálmán J
    Psychiatr Hung; 2012; 27(2):82-91. PubMed ID: 22700619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.